EXTON, Pa.--(BUSINESS WIRE)--ThingWorx™ today announced that Biocartis, an innovative molecular diagnostics company, has selected ThingWorx as the Machine-to-Machine (M2M) application platform to power its next-generation remote service offering. Biocartis intends to use the ThingWorx application platform to provide remote instrument connectivity and innovative M2M applications, extending its molecular diagnostics solution with high-value remote service and value-added offerings for its customers and partners. ThingWorx enables Biocartis to bring to market a next-generation remote service solution for its Molecular Diagnostics Platform, a unique DNA-based in vitro diagnostics system that it is currently developing for the emerging needs of personalized medicine. Biocartis is utilizing the rapid application development tools and M2M communications technology provided by the ThingWorx platform to develop the remote service solution. Using the extensibility and enterprise integration features that are core to the ThingWorx platform, Biocartis aims to deliver innovative, value-added services in addition to remote instrument monitoring.
Help employers find you! Check out all the jobs and post your resume.
